Comparative Cost-Effectiveness Analysis of Adding Twice-Daily Exenatide To Insulin Glargine Versus Adding Insulin Lispro To Treat Type 2 Diabetes In Spain
Value Health
.
2014 Nov;17(7):A349-50.
doi: 10.1016/j.jval.2014.08.723.
Epub 2014 Oct 26.
Authors
J Sánchez-Covisa
1
,
M Capel
1
,
S Baeten
2
,
B G Verheggen
2
Affiliations
1
AstraZeneca, Madrid, Spain.
2
Pharmerit International, Rotterdam, The Netherlands.
PMID:
27200673
DOI:
10.1016/j.jval.2014.08.723
No abstract available